NattoPharma marks China entry with its MenaQ7 vitamin K2 product

By Gary Scattergood contact

- Last updated on GMT

Related tags: Dietary supplement, Nutrition

Youwen Chen, FishBurg CEO and Daniel Rosenbaum, NattoPharma CEO pictured after signing the deal.
Youwen Chen, FishBurg CEO and Daniel Rosenbaum, NattoPharma CEO pictured after signing the deal.
Vitamin K2 supplier NattoPharma has made a major move into the China market via a bone health supplement launched by manufacturer FishBurg.

FishBurg, a major player in the calcium/vitamin D3 (VD3) segment, signed a partnership and supply agreement with NattoPharma for its MenaQ7 vitamin K2 as MK-7 ingredient in Guangzhou earlier this week.

During this event, FishBurg officially launched its new Blue Hat-registered Calcium/VD3/MenaQ7 Vitamin K2 supplement for bone health to the Chinese market.

The event was attended by 150 distributors from across China, who will promote the new FishBurg product via pharmacies and other Chinese dietary supplement channels.

'Amazing potential'

“The product launch is a clear indication of the commitment from both parties,”​ said Daniel Rosenbaum, NattoPharma CEO. “The event created excitement around MenaQ7 Vitamin K2, which has amazing market potential in China.”  

NattoPharma’s Chinese distributor partner Prochin hosted the event. According to Jordan Yang, the commercial director of Prochin, distributors were excited to learn about MenaQ7's arrival in China.

“FishBurg is quite confident that the newly launched Calcium/VD3/MenaQ7 Vitamin K2 product will have a very impressive impact on the Chinese nutritional market, bringing the benefits of bone and cardiovascular health to all customers,”​ said Youwen Chen, the CEO of FishBurg.

Related news

Related products

show more

Human Bifidobacteria, selected by Mother’s milk

Human Bifidobacteria, selected by Mother’s milk

Morinaga Milk Industry Co., Ltd. | 01-Nov-2018 | Technical / White Paper

Health promoting traits of Bifidobacteria are well-known around the world and its effect is strain-specific, however, whether the residential origin of...

K2 for Heart Health? MenaQ7 Only Proven, Patented

K2 for Heart Health? MenaQ7 Only Proven, Patented

NattoPharma USA, Inc. | 22-Oct-2018 | Research Study

Vitamin K2 has earned media and the medical community’s attention due to a strong body of evidence showing it simultaneously supports bone and cardiovascular...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars